NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Vial

Vial

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://vial.com/

Last Round

Debt

Jun 18, 2025

Total Funding Raised

$144M

Company Overview

Vial is a next-generation pharmaceutical company that operates a tech-enabled clinical research organization (CRO) and develops computationally designed therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

contract research organizationCROclinical trial managementclinical trial softwaretech-enabled CROclinical research servicesclinical operationstrial automationoncology CRObiotech researchclinical trial platformeClinicaldrug developmentclinical trial site coordinationSaaS clinical software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vial Comparables

Compare Vial with similar companies based on industry and business-model similarity.

Vial comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lindus Health
88%
Curebase
84%
IQVIA Holdings Inc.
75%

Vial Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJun 18, 2025
Series BNov 30, 2022
Series ANov 1, 2022
SeedApr 1, 2021

Key People

Founding team and executive leadership

Simon Burns

Co-Founder And CEO

Founding Team

Joshua Pascoe

Chief Operating Officer

Executive Team

Vial Investors

Notable investors and investment history

Vial investors
InvestorRounds
Andreessen HorowitzSeries A
Byers CapitalSeries A, Series B
Buckley VenturesSeries A, Seed
General CatalystSeries A, Series B
BoxGroupSeries A, Series B
Base10 PartnersSeries A
ATEL VenturesDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 30, 2022

    $67M round completed.

Vial Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vial Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vial's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range157
Year Founded2020
Last FundingJun 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.